Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine

 RIO DE JANEIRO - Brazil's health regulator Anvisa said in a statement on Friday it authorized Sao Paulo's Butantan Institute biomedical center to import 6 million doses of a coronavirus vaccine candidate developed by China's Sinovac .
The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy